TY  - JOUR
AU  - Vicente Zurdo, David
AU  - Brunetti, Leonardo
AU  - Piemontese, Luca
AU  - Guedes, Beatriz
AU  - Cardoso, Sandra
AU  - Chavarria, Daniel
AU  - Borges, Fernanda
AU  - Madrid, Yolanda
AU  - Chaves, Sílvia
AU  - Santos, M.
PY  - 2023
DO  - 10.3390/ijms24098312
SN  - 1422-0067
UR  - https://hdl.handle.net/20.500.14352/110005
T2  - Internationl Journal of Molecular Sciences
AB  - With the goal of combating the multi-faceted Alzheimer’s disease (AD), a series of Rivastigmine-Benzimidazole (RIV–BIM) hybrids was recently reported by us as multitarget-directed ligands, thanks to their capacity to tackle important...
LA  - eng
M2  - 8312
PB  - MDPI
KW  - Alzheimer’s disease
KW  - Parkinson’s disease
KW  - Rivastigmine hybrids
KW  - Metal chelation
KW  - Cholinesterases
KW  - Monoamine oxidase
KW  - Amyloid-β aggregation
TI  - Rivastigmine-benzimidazole hybrids as promising multitarget metal-modulating compounds for potential treatment of neurodegenerative diseases
TY  - journal article
VL  - 24
ER  -